Literature DB >> 20519032

Management of sodium disorders during continuous haemofiltration.

Marlies Ostermann, Helen Dickie, Linda Tovey, David Treacher.   

Abstract

In patients with acute kidney injury and concomitant severe hyponatraemia or hypernatraemia, rapid correction of the serum Na+ concentration needs to be avoided. The present paper outlines the principles of how to adjust the Na+ concentration in the replacement fluid during continuous renal replacement therapy to prevent rapid changes of the serum Na+ concentration.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20519032      PMCID: PMC2911705          DOI: 10.1186/cc9002

Source DB:  PubMed          Journal:  Crit Care        ISSN: 1364-8535            Impact factor:   9.097


Introduction

Continuous venovenous haemofiltration (CVVH) is an established treatment for patients with acute kidney injury. During CVVH, serum electrolyte concentrations tend to equilibrate with their concentrations in the replacement fluid. The rate at which this happens depends on the difference in their concentrations between serum and replacement fluid, and on the rate of treatment. Patients presenting with acute kidney injury may have concomitant severe hyponatraemia or hypernatraemia. Over-rapid correction of the serum Na+ concentration is associated with pontine myelinosis and/or cerebral oedema [1,2]. If CVVH is needed, the Na+ concentration in the replacement fluid (usually 140 mmol/l) needs to be adjusted in order to avoid rapid changes of the serum Na+ concentration. In the present paper we provide some guidance on how to make these adjustments for CVVH. The same principle could be applied for continuous haemo dialysis or diafiltration.

Acute kidney injury and hypernatraemia (Na+ >155 mmol/l)

Free water hydration is the first-line therapy if possible. If CVVH is necessary, the Na+ concentration of the replacement fluid should be increased by adding concentrated NaCl solution (Table 1).
Table 1

Effect of adding different volumes of 30% NaCl to replacement fluid

Volume of 30% NaCl addedNil5 ml (= 25 mmol Na+)10 ml (= 50 mmol Na+)15 ml (= 75 mmol Na+)20 ml (= 100 mmol Na+)
Final Na+ concentration in replacement fluid140 mmol/l145 mmol/l150 mmol/l155 mmol/l160 mmol/l

Effect of adding different volumes of 30% NaCl (≈5 mmol/ml) to a 5 l bag of replacement fluid containing a Na+ concentration of 140 mmol/l.

Effect of adding different volumes of 30% NaCl to replacement fluid Effect of adding different volumes of 30% NaCl (≈5 mmol/ml) to a 5 l bag of replacement fluid containing a Na+ concentration of 140 mmol/l. Generally, it is not considered safe to lower the serum Na+ concentration by more than 8 to 10 mmol/l over 24 hours, especially in the setting of chronic hypernatraemia [1]. Usually, a stepwise correction of the patient's serum Na+ concentration is planned using replacement fluid made up to successively lower Na+ concentrations. If the serum Na+ decreases by >2 mmol/l in 6 hours, either the rate of filtration should be decreased or the fluid bags should be changed to bags with a higher Na+ concentration. The volumes of 30% NaCl added are small and will not affect the concentration of other electrolytes in the solution significantly.

Acute kidney injury and hyponatraemia (Na+ <125 mmol/l)

If CVVH is needed, the Na+ concentration of the replacement fluid should be reduced by adding sterile water (Table 2). Generally, it is not considered safe to increase the serum Na+ concentration by more than 8 to 10 mmol/l over 24 hours, especially in chronic hyponatraemia [2]. Usually, a stepwise correction of the patient's serum Na+ concentration is planned using replacement fluid made up to successively higher Na+ concentrations.
Table 2

Effect of adding different volumes of water to replacement fluid

Volume of water added (ml)Final volume of diluted replacement fluid (l)[Na+] in diluted replacement fluid (mmol/l)[HCO3-] in diluted replacement fluid (mmol/l)[K+] in diluted replacement fluid containing 4 mmol/l
Nil5140354.0
1505.15136343.9
2505.25133333.8
3505.35131333.7
5005.5127323.6
7505.75122303.5
1,0006.0117293.3
1,2506.25112283.2

Effect of adding different volumes of water to a 5 l bag of replacement fluid with a Na+ concentration of 140 mmol/l. [Na+], sodium concentration; [HCO3-], bicarbonate concentration; [K+], potassium concentration.

Effect of adding different volumes of water to replacement fluid Effect of adding different volumes of water to a 5 l bag of replacement fluid with a Na+ concentration of 140 mmol/l. [Na+], sodium concentration; [HCO3-], bicarbonate concentration; [K+], potassium concentration. If the serum Na+ concentration has increased by >2 mmol/l in 6 hours, either the rate of filtration should be decreased or the fluid bags should be changed to bags with a lower Na+ concentration. The concentration of bicarbonate and potassium in the final solution will also be reduced, and the patient may need additional supplementation.

Abbreviations

CVVH: continuous venovenous haemofiltration.

Competing interests

The authors declare that they have no competing interests.
  2 in total

Review 1.  Hyponatremia.

Authors:  H J Adrogué; N E Madias
Journal:  N Engl J Med       Date:  2000-05-25       Impact factor: 91.245

Review 2.  Hypernatremia.

Authors:  H J Adrogué; N E Madias
Journal:  N Engl J Med       Date:  2000-05-18       Impact factor: 91.245

  2 in total
  13 in total

1.  Intensive care management of severe hypernatraemia in the context of group A streptococcal septicaemia.

Authors:  Bethan Davies; Robert Jesty; Shahana Uddin; Victoria Metaxa
Journal:  BMJ Case Rep       Date:  2018-04-26

Review 2.  Delivering optimal renal replacement therapy to critically ill patients with acute kidney injury.

Authors:  Ron Wald; William Beaubien-Souligny; Rahul Chanchlani; Edward G Clark; Javier A Neyra; Marlies Ostermann; Samuel A Silver; Suvi Vaara; Alexander Zarbock; Sean M Bagshaw
Journal:  Intensive Care Med       Date:  2022-09-06       Impact factor: 41.787

Review 3.  Clinical Implications, Evaluation, and Management of Hyponatremia in Cirrhosis.

Authors:  Dibya L Praharaj; Anil C Anand
Journal:  J Clin Exp Hepatol       Date:  2021-09-16

Review 4.  Dysnatremias in patients with kidney disease.

Authors:  Sara Combs; Tomas Berl
Journal:  Am J Kidney Dis       Date:  2013-11-14       Impact factor: 8.860

Review 5.  Clinical review: use of renal replacement therapies in special groups of ICU patients.

Authors:  Eric A J Hoste; Annemieke Dhondt
Journal:  Crit Care       Date:  2012-01-19       Impact factor: 9.097

6.  Successful management of severe hyponatraemia during continuous renal replacement therapy.

Authors:  Diana Vassallo; Denise Camilleri; Vicki Moxham; Marlies Ostermann
Journal:  Clin Kidney J       Date:  2012-03-07

7.  Continuous venovenous hemofiltration using customized replacement fluid for acute kidney injury with severe hypernatremia.

Authors:  François Paquette; Rémi Goupil; François Madore; Stéphan Troyanov; Josée Bouchard
Journal:  Clin Kidney J       Date:  2016-05-26

8.  Management of Severe Hyponatremia With a Custom Continuous Renal Replacement Therapy in an Infant With Newly Diagnosed Chronic Kidney Disease.

Authors:  Marie-Michèle Gaudreault-Tremblay; Hassan Faqeehi; Valérie Langlois; Diane Hébert; Dimitri A Parra; Gail Annich; Elizabeth Harvey; Mathieu Lemaire
Journal:  Kidney Int Rep       Date:  2017-07-20

Review 9.  Clinical review: practical approach to hyponatraemia and hypernatraemia in critically ill patients.

Authors:  Christian Overgaard-Steensen; Troels Ring
Journal:  Crit Care       Date:  2013-02-27       Impact factor: 9.097

10.  A Multidisciplinary Approach for the Management of Severe Hyponatremia in Patients Requiring Continuous Renal Replacement Therapy.

Authors:  Javier A Neyra; Victor M Ortiz-Soriano; Dina Ali; Peter E Morris; Clayton M Johnston
Journal:  Kidney Int Rep       Date:  2018-09-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.